Obesity Trial, Recruiting (NCT05147909)

Obesity Trial, Recruiting NCT05147909 Sponsor: University of Texas Southwestern Medical Center Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT05147909 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are generally healthy, without diabetes, kidney disease, heart or blood vessel disease, or any current use of medications that affect blood pressure or circulation

Who may not be able to join:

People who have a history of heart or lung disease, or chronic kidney disease
People who take medications to lower blood pressure
People whose kidneys are not filtering blood well enough (based on a specific blood test result — confirm with trial site)
People who have diabetes or any other ongoing systemic illness
People who are pregnant
People who have had an allergic reaction to sodium phosphate in the past
People with any history of substance abuse, or who currently smoke cigarettes
People with any history of a psychiatric illness
People with a history of active cancer
People whose blood phosphorus levels fall outside a specific normal range (based on a blood test result — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wanpen Vongpatanasin, MD, Wanpen.Vongpatanasin@UTSouthwestern.edu

Phone: 2146484403

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05147909

Sponsor: University of Texas Southwestern Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

Trial contact: 2146484403

More information: https://clinicaltrials.gov/study/NCT05147909

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are generally healthy, without diabetes, kidney disease, heart or blood vessel disease, or any current use of medications that affect blood pressure or circulation

Who may not be able to join:

People who have a history of heart or lung disease, or chronic kidney disease
People who take medications to lower blood pressure
People whose kidneys are not filtering blood well enough (based on a specific blood test result — confirm with trial site)
People who have diabetes or any other ongoing systemic illness
People who are pregnant
People who have had an allergic reaction to sodium phosphate in the past
People with any history of substance abuse, or who currently smoke cigarettes
People with any history of a psychiatric illness
People with a history of active cancer
People whose blood phosphorus levels fall outside a specific normal range (based on a blood test result — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Texas Southwestern Medical Center

Registry

ClinicalTrials.gov

Start date

14 September 2022

Est. completion

31 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

oxygen uptake (VO2) during peak exercise

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov